SCHEMBL4446257

SCHEMBL4446257

COc1ccccc1C(=O)C=Cc1c(OC)cc(OC)c(OC)c1OC

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 1/20 0.65
▸ ABCG2 Q9UNQ0 4/20 0.62
▸ ALDH1A1 P00352 1/20 0.56
▸ LMNA P02545 1/20 0.56
▸ MAPT P10636 1/20 0.56
▸ MAOB P27338 2/20 0.52
▸ AR P10275 2/20 0.51
▸ KRAS P01116 1/20 0.50
▸ TNFRSF1A P19438 1/20 0.50
▸ CYP3A4 P08684 1/20 0.49
▸ MCL1 Q07820 1/20 0.49
▸ TUBB4A P04350 1/20 0.48
▸ TUBB P07437 1/20 0.48
▸ TUBA3C P0DPH7 1/20 0.48
▸ TUBA1B P68363 1/20 0.48
▸ TUBA4A P68366 1/20 0.48
▸ TUBB4B P68371 1/20 0.48
▸ TUBB3 Q13509 1/20 0.48
▸ TUBB2A Q13885 1/20 0.48
▸ TUBB8 Q3ZCM7 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7187233 0.84 TNFRSF1A (0.62) ABCB1ABCG2ALDH1A1LMNAMAPT
SCHEMBL7187236 0.84 TNFRSF1A (0.62) ABCB1ABCG2ALDH1A1LMNAMAPT
SCHEMBL3649269 0.84 TNFRSF1A (0.52) ABCB1ABCG2ALDH1A1LMNAMAPT
SCHEMBL18593318 0.79 ABCB1 (1.00) ABCB1ABCG2ALDH1A1LMNAMAPT
SCHEMBL7191889 0.78 PDE4A (0.60) ABCB1ABCG2ALDH1A1LMNAMAPT
SCHEMBL7191886 0.78 PDE4A (0.60) ABCB1ABCG2ALDH1A1LMNAMAPT
SCHEMBL31167606 0.78 ABCG2 (0.77) ABCB1ABCG2MAOBARCYP3A4
SCHEMBL18593317 0.77 ABCG2 (0.66) ABCB1ABCG2MAOBARCYP3A4
SCHEMBL29211623 0.77 ABCG2 (0.66) ABCB1ABCG2ALDH1A1LMNAMAPT
SCHEMBL1764951 0.77 NFE2L2 (0.70) ABCG2ALDH1A1LMNAMAPTMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090182058-A1 Novel Chalcone Derivatives With Antimitotic Activity UNIVERSITE JOSEPH FOURIER GRENOBLE I (FR) 2009-07-16 — — US claimed
US-20090182058-A1 Novel Chalcone Derivatives With Antimitotic Activity UNIVERSITE JOSEPH FOURIER GRENOBLE I (FR) 2009-07-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090182058-A1 Novel Chalcone Derivatives With Antimitotic Activity ABCE1, CCNE1, FOXM1 ABCB1 122/4885ABCG2 38/4885ALDH1A1 3972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback